Delphi Study

Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direct acting antiviral therapies. Reliable disease burden estimates are required for national strategies. This analysis estimates the global prevalence of viraemic HCV at the end of 2015, an update of—and expansion on—the 2014 analysis, which reported 80 million (95% CI 64–103) viraemic infections in 2013.
Background As global efforts to increase the nursing and midwifery workforce intensify to improve access and quality of healthcare, clinical nursing and midwifery research must increase concomitantly to provide a solid evidence base for these clinicians. To maximize research resources in resource-poor regions, the research team collaborated with regional experts in southern and eastern African countries to convene a Research Summit in Nairobi, Kenya.